DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ advanced 4.07% to $676.23 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.45% to 7,503.85 and Dow Jones Industrial Average falling 0.25% to 52,925.15.
Regeneron Pharmaceuticals Inc. closed 17.64% below its 52-week high of $821.11, which the company reached on January 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Amgen Inc. $(AMGN)$ rose 0.45% to $368.10, Moderna Inc. (MRNA) fell 2.48% to $79.77, and Gilead Sciences Inc. (GILD) rose 5.21% to $136.36.
Trading volume (917,952) remained 165,978 below its 50-day average volume of 1.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 7, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 07, 2026 16:44 ET (20:44 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments